{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:46:42Z","timestamp":1787507202183,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Drug Safety Science Centre, University of Liverpool, UK, and Nippi, Inc., Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55720-5","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:46:53Z","timestamp":1780120013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of fluoroquinolone antibiotics on extracellular matrix-related phenotypes in tendon cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Akshay","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadatoshi","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kazaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"55720_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1369-5274(99)00003-X","volume":"2","author":"VJ Lee","year":"1999","unstructured":"Lee, V. J., Miller, G. H. & Yagisawa, M. What\u2019s new in the antibiotic pipeline. Curr. Opin. Microbiol. 2, 475\u2013482 (1999).","journal-title":"Curr. Opin. Microbiol."},{"key":"55720_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1056\/nejm199102073240606","volume":"324","author":"DC Hooper","year":"1991","unstructured":"Hooper, D. C. & Wolfson, J. S. Fluoroquinolone antimicrobial agents. N. Engl. J. Med. 324, 384\u2013394. https:\/\/doi.org\/10.1056\/nejm199102073240606 (1991).","journal-title":"N. Engl. J. Med."},{"key":"55720_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020184","author":"E Duman","year":"2025","unstructured":"Duman, E. et al. Fluoroquinolone-mediated tendinopathy and tendon rupture. Pharmaceuticals (Basel, Switzerland) https:\/\/doi.org\/10.3390\/ph18020184 (2025).","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"55720_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02258-1","volume":"21","author":"C Jun","year":"2021","unstructured":"Jun, C. & Fang, B. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection. BMC Cardiovasc. Disord. 21, 470. https:\/\/doi.org\/10.1186\/s12872-021-02258-1 (2021).","journal-title":"BMC Cardiovasc. Disord."},{"key":"55720_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010077","volume":"5","author":"N Daneman","year":"2015","unstructured":"Daneman, N., Lu, H. & Redelmeier, D. A. Fluoroquinolones and collagen associated severe adverse events: A longitudinal cohort study. BMJ Open 5, e010077. https:\/\/doi.org\/10.1136\/bmjopen-2015-010077 (2015).","journal-title":"BMJ Open"},{"key":"55720_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k678","volume":"360","author":"B Pasternak","year":"2018","unstructured":"Pasternak, B., Inghammar, M. & Svanstr\u00f6m, H. Fluoroquinolone use and risk of aortic aneurysm and dissection: Nationwide cohort study. BMJ 360, k678. https:\/\/doi.org\/10.1136\/bmj.k678 (2018).","journal-title":"BMJ"},{"key":"55720_CR7","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1001\/jama.2013.280500","volume":"310","author":"B Pasternak","year":"2013","unstructured":"Pasternak, B., Svanstr\u00f6m, H., Melbye, M. & Hviid, A. Association between oral fluoroquinolone use and retinal detachment. JAMA 310, 2184\u20132190. https:\/\/doi.org\/10.1001\/jama.2013.280500 (2013).","journal-title":"JAMA"},{"issue":"5","key":"55720_CR8","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1111\/aos.12931","volume":"94","author":"C Alves","year":"2016","unstructured":"Alves, C., Penedones, A., Mendes, D. & Batel Marques, F. A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment. Acta Ophthalmol. 94(5), e251\u2013e259. https:\/\/doi.org\/10.1111\/aos.12931 (2016).","journal-title":"Acta Ophthalmol."},{"key":"55720_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/jac\/dku507","volume":"70","author":"CS Chui","year":"2015","unstructured":"Chui, C. S., Wong, I. C., Wong, L. Y. & Chan, E. W. Association between oral fluoroquinolone use and the development of retinal detachment: A systematic review and meta-analysis of observational studies. J. Antimicrob. Chemother. 70, 971\u2013978. https:\/\/doi.org\/10.1093\/jac\/dku507 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"55720_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8023935","volume":"2017","author":"K Michalak","year":"2017","unstructured":"Michalak, K. et al. Treatment of the fluoroquinolone-associated disability: The pathobiochemical implications. Oxid. Med. Cell. Longev. 2017, 8023935-8023935. https:\/\/doi.org\/10.1155\/2017\/8023935 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"55720_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.urology.2017.10.017","volume":"113","author":"AL Godoy-Santos","year":"2018","unstructured":"Godoy-Santos, A. L. et al. Fluoroquinolones and the risk of Achilles tendon disorders: Update on a neglected complication. Urology 113, 20\u201325. https:\/\/doi.org\/10.1016\/j.urology.2017.10.017 (2018).","journal-title":"Urology"},{"key":"55720_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd4461","volume":"14","author":"SK Nigam","year":"2015","unstructured":"Nigam, S. K. What do drug transporters really do?. Nat. Rev. Drug Discov. 14, 29\u201344. https:\/\/doi.org\/10.1038\/nrd4461 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55720_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1517\/17425255.2012.674512","volume":"8","author":"A Mulgaonkar","year":"2012","unstructured":"Mulgaonkar, A., Venitz, J. & Sweet, D. H. Fluoroquinolone disposition: Identification of the contribution of renal secretory and reabsorptive drug transporters. Expert Opin. Drug Metab. Toxicol. 8, 553\u2013569. https:\/\/doi.org\/10.1517\/17425255.2012.674512 (2012).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"55720_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0091270002424013","volume":"42","author":"AL Neuhofel","year":"2002","unstructured":"Neuhofel, A. L., Wilton, J. H., Victory, J. M., Hejmanowski, L. G. & Amsden, G. W. Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: A new twist on an old interaction. J. Clin. Pharmacol. 42, 461\u2013466. https:\/\/doi.org\/10.1177\/0091270002424013 (2002).","journal-title":"J. Clin. Pharmacol."},{"key":"55720_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/0009-9236(95)90173-6","volume":"58","author":"U Jaehde","year":"1995","unstructured":"Jaehde, U. et al. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Clin. Pharmacol. Ther. 58, 532\u2013541. https:\/\/doi.org\/10.1016\/0009-9236(95)90173-6 (1995).","journal-title":"Clin. Pharmacol. Ther."},{"key":"55720_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrrheum.2015.26","volume":"11","author":"G Nourissat","year":"2015","unstructured":"Nourissat, G., Berenbaum, F. & Duprez, D. Tendon injury: From biology to tendon repair. Nat. Rev. Rheumatol. 11, 223\u2013233. https:\/\/doi.org\/10.1038\/nrrheum.2015.26 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"55720_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/bmb\/ldr025","volume":"99","author":"T Sakabe","year":"2011","unstructured":"Sakabe, T. & Sakai, T. Musculoskeletal diseases\u2014Tendon. Br. Med. Bull. 99, 211\u2013225. https:\/\/doi.org\/10.1093\/bmb\/ldr025 (2011).","journal-title":"Br. Med. Bull."},{"key":"55720_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108353","volume":"301","author":"T Sakai","year":"2025","unstructured":"Sakai, T. & Kumagai, K. Molecular dissection of tendon development and healing: Insights into tenogenic phenotypes and functions. J. Biol. Chem. 301, 108353. https:\/\/doi.org\/10.1016\/j.jbc.2025.108353 (2025).","journal-title":"J. Biol. Chem."},{"key":"55720_CR19","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1096\/fj.12-225599","volume":"27","author":"KM Heinemeier","year":"2013","unstructured":"Heinemeier, K. M., Schjerling, P., Heinemeier, J., Magnusson, S. P. & Kjaer, M. Lack of tissue renewal in human adult Achilles tendon is revealed by nuclear bomb 14C. FASEB J. 27, 2074\u20132079. https:\/\/doi.org\/10.1096\/fj.12-225599 (2013).","journal-title":"FASEB J."},{"key":"55720_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/bs.ctdb.2018.11.004","volume":"133","author":"CC Yeung","year":"2019","unstructured":"Yeung, C. C. & Kadler, K. E. Importance of the circadian clock in tendon development. Curr. Top. Dev. Biol. 133, 309\u2013342. https:\/\/doi.org\/10.1016\/bs.ctdb.2018.11.004 (2019).","journal-title":"Curr. Top. Dev. Biol."},{"key":"55720_CR21","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1096\/fj.201701569R","volume":"32","author":"KM Heinemeier","year":"2018","unstructured":"Heinemeier, K. M. et al. Carbon-14 bomb pulse dating shows that tendinopathy is preceded by years of abnormally high collagen turnover. FASEB J. 32, 4763\u20134775. https:\/\/doi.org\/10.1096\/fj.201701569R (2018).","journal-title":"FASEB J."},{"key":"55720_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijantimicag.2009.10.009","volume":"35","author":"J Sendzik","year":"2010","unstructured":"Sendzik, J., Shakibaei, M., Sch\u00e4fer-Korting, M., Lode, H. & Stahlmann, R. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int. J. Antimicrob. Agents 35, 366\u2013374. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.10.009 (2010).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"55720_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.1804","volume":"153","author":"SA LeMaire","year":"2018","unstructured":"LeMaire, S. A. et al. Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice. JAMA Surg. 153, e181804. https:\/\/doi.org\/10.1001\/jamasurg.2018.1804 (2018).","journal-title":"JAMA Surg."},{"key":"55720_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/jac\/31.3.331","volume":"31","author":"D Decr\u00e9","year":"1993","unstructured":"Decr\u00e9, D. & Bergogne-B\u00e9r\u00e9zin, E. Pharmacokinetics of quinolones with special reference to the respiratory tree. J. Antimicrob. Chemother. 31, 331\u2013343 (1993).","journal-title":"J. Antimicrob. Chemother."},{"key":"55720_CR25","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1021\/acs.molpharmaceut.8b00547","volume":"15","author":"D Dickens","year":"2018","unstructured":"Dickens, D. et al. Cellular uptake of the atypical antipsychotic clozapine is a carrier-mediated process. Mol. Pharm. 15, 3557\u20133572. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00547 (2018).","journal-title":"Mol. Pharm."},{"key":"55720_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/mp060082j","volume":"4","author":"T Maeda","year":"2007","unstructured":"Maeda, T. et al. Identification of influx transporter for the quinolone antibacterial agent levofloxacin. Mol. Pharm. 4, 85\u201394 (2007).","journal-title":"Mol. Pharm."},{"key":"55720_CR27","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/AAC.01428-08","volume":"53","author":"B Marquez","year":"2009","unstructured":"Marquez, B., Caceres, N. E., Mingeot-Leclercq, M. P., Tulkens, P. M. & Van Bambeke, F. Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: Studies with ciprofloxacin-resistant cells. Antimicrob. Agents Chemother. 53, 2410\u20132416. https:\/\/doi.org\/10.1128\/AAC.01428-08 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"55720_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/sj.clpt.6100104","volume":"81","author":"DG Bailey","year":"2007","unstructured":"Bailey, D. G., Dresser, G. K., Leake, B. F. & Kim, R. B. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin. Pharmacol. Ther. 81, 495\u2013502. https:\/\/doi.org\/10.1038\/sj.clpt.6100104 (2007).","journal-title":"Clin. Pharmacol. Ther."},{"key":"55720_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","volume":"34","author":"B Hagenbuch","year":"2013","unstructured":"Hagenbuch, B. & Stieger, B. The SLCO (former SLC21) superfamily of transporters. Mol. Asp. Med. 34, 396\u2013412. https:\/\/doi.org\/10.1016\/j.mam.2012.10.009 (2013).","journal-title":"Mol. Asp. Med."},{"key":"55720_CR30","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/jcs.01731","volume":"118","author":"EG Canty","year":"2005","unstructured":"Canty, E. G. & Kadler, K. E. Procollagen trafficking, processing and fibrillogenesis. J. Cell Sci. 118, 1341\u20131353 (2005).","journal-title":"J. Cell Sci."},{"key":"55720_CR31","doi-asserted-by":"crossref","unstructured":"Saneyasu, T., Yoshioka, S. & Sakai, T. Mechanisms of collagen network organization in response to tissue\/organ damage. In: Composition and Function of the Extracellular Matrix in the Human Body, pp. 235-260 (2016).","DOI":"10.5772\/63163"},{"key":"55720_CR32","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1053\/j.gastro.2011.02.005","volume":"140","author":"K Moriya","year":"2011","unstructured":"Moriya, K. et al. A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling. Gastroenterology 140, 1653\u20131663. https:\/\/doi.org\/10.1053\/j.gastro.2011.02.005 (2011).","journal-title":"Gastroenterology"},{"key":"55720_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1074\/jbc.M115.691519","volume":"291","author":"A Iwasaki","year":"2016","unstructured":"Iwasaki, A. et al. Molecular mechanism responsible for fibronectin-controlled alterations in matrix stiffness in advanced chronic liver fibrogenesis. J. Biol. Chem. 291, 72\u201388. https:\/\/doi.org\/10.1074\/jbc.M115.691519 (2016).","journal-title":"J. Biol. Chem."},{"key":"55720_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2125.2004.02059.x","volume":"57","author":"R Bellmann","year":"2004","unstructured":"Bellmann, R. et al. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br. J. Clin. Pharmacol. 57, 563\u2013568. https:\/\/doi.org\/10.1111\/j.1365-2125.2004.02059.x (2004).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"55720_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2021.100079","volume":"12","author":"CK Revell","year":"2021","unstructured":"Revell, C. K. et al. Collagen fibril assembly: New approaches to unanswered questions. Matrix Biol. Plus 12, 100079. https:\/\/doi.org\/10.1016\/j.mbplus.2021.100079 (2021).","journal-title":"Matrix Biol. Plus"},{"key":"55720_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.33594\/000000743","volume":"58","author":"M Sta\u0144czak","year":"2024","unstructured":"Sta\u0144czak, M., Kacprzak, B. & Gawda, P. Tendon cell biology: Effect of mechanical loading. Cell. Physiol. Biochem. 58, 677\u2013701. https:\/\/doi.org\/10.33594\/000000743 (2024).","journal-title":"Cell. Physiol. Biochem."},{"key":"55720_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6603(01)70012-8","volume":"70","author":"K Csiszar","year":"2001","unstructured":"Csiszar, K. Lysyl oxidases: A novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70, 1\u201332 (2001).","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"55720_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1083\/jcb.141.2.527","volume":"141","author":"T Sakai","year":"1998","unstructured":"Sakai, T., Zhang, Q., Fassler, R. & Mosher, D. F. Modulation of \u03b21A integrin functions by tyrosine residues in the \u03b21 cytoplasmic domain. J. Cell Biol. 141, 527\u2013538 (1998).","journal-title":"J. Cell Biol."},{"key":"55720_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2131\/jts.36.339","volume":"36","author":"E Olcay","year":"2011","unstructured":"Olcay, E. et al. Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: Comparison of biomechanical and histopathological effects on Achilles tendon in rats. J. Toxicol. Sci. 36, 339\u2013345. https:\/\/doi.org\/10.2131\/jts.36.339 (2011).","journal-title":"J. Toxicol. Sci."},{"key":"55720_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0968-4328(00)00043-3","volume":"32","author":"DE Birk","year":"2001","unstructured":"Birk, D. E. Type V collagen: Heterotypic type I\/V collagen interactions in the regulation of fibril assembly. Micron 32, 223\u2013237 (2001).","journal-title":"Micron"},{"key":"55720_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/03008208609017469","volume":"14","author":"E Adachi","year":"1986","unstructured":"Adachi, E. & Hayashi, T. In vitro formation of hybrid fibrils of type V collagen and type I collagen. Limited growth of type I collagen into thick fibrils by type V collagen.. Connect. Tissue Res. 14, 257\u2013266 (1986).","journal-title":"Connect. Tissue Res."},{"key":"55720_CR42","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.3390\/molecules180911153","volume":"18","author":"V Uivarosi","year":"2013","unstructured":"Uivarosi, V. Metal complexes of quinolone antibiotics and their applications: An update. Molecules 18, 11153\u201311197. https:\/\/doi.org\/10.3390\/molecules180911153 (2013).","journal-title":"Molecules"},{"key":"55720_CR43","doi-asserted-by":"publisher","first-page":"22287","DOI":"10.1074\/jbc.M115.671222","volume":"290","author":"S Badal","year":"2015","unstructured":"Badal, S., Her, Y. F. & Maher, L. J. 3rd. Nonantibiotic effects of fluoroquinolones in mammalian cells. J. Biol. Chem. 290, 22287\u201322297. https:\/\/doi.org\/10.1074\/jbc.M115.671222 (2015).","journal-title":"J. Biol. Chem."},{"key":"55720_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","volume":"41","author":"T Klein","year":"2011","unstructured":"Klein, T. & Bischoff, R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41, 271\u2013290. https:\/\/doi.org\/10.1007\/s00726-010-0689-x (2011).","journal-title":"Amino Acids"},{"key":"55720_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1034\/j.1600-065X.2002.18613.x","volume":"186","author":"J Takagi","year":"2002","unstructured":"Takagi, J. & Springer, T. A. Integrin activation and structural rearrangement. Immunol. Rev. 186, 141\u2013163 (2002).","journal-title":"Immunol. Rev."},{"key":"55720_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s002040000203","volume":"75","author":"M Shakibaei","year":"2001","unstructured":"Shakibaei, M. & Stahlmann, R. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch. Toxicol. 75, 97\u2013102 (2001).","journal-title":"Arch. Toxicol."},{"issue":"Suppl 2","key":"55720_CR47","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","volume":"12","author":"AP Gilmore","year":"2005","unstructured":"Gilmore, A. P. Anoikis. Cell Death Differ. 12(Suppl 2), 1473\u20131477. https:\/\/doi.org\/10.1038\/sj.cdd.4401723 (2005).","journal-title":"Cell Death Differ."},{"key":"55720_CR48","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch, S. M. & Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell. Biol. 124, 619\u2013626. https:\/\/doi.org\/10.1083\/jcb.124.4.619 (1994).","journal-title":"J. Cell. Biol."},{"key":"55720_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/hep.25624","volume":"56","author":"K Moriya","year":"2012","unstructured":"Moriya, K., Sakai, K., Yan, M. H. & Sakai, T. Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice.. Hepatology 56, 311\u2013321. https:\/\/doi.org\/10.1002\/hep.25624 (2012).","journal-title":"Hepatology"},{"key":"55720_CR50","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1074\/jbc.RA118.001987","volume":"293","author":"T Sakabe","year":"2018","unstructured":"Sakabe, T. et al. Transcription factor scleraxis vitally contributes to progenitor lineage direction in wound healing of adult tendon in mice. J. Biol. Chem. 293, 5766\u20135780. https:\/\/doi.org\/10.1074\/jbc.RA118.001987 (2018).","journal-title":"J. Biol. Chem."},{"key":"55720_CR51","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cub.2011.04.007","volume":"21","author":"T Maeda","year":"2011","unstructured":"Maeda, T. et al. Conversion of mechanical force into TGF-\u03b2-mediated biochemical signals. Curr. Biol. 21, 933\u2013941. https:\/\/doi.org\/10.1016\/j.cub.2011.04.007 (2011).","journal-title":"Curr. Biol."},{"key":"55720_CR52","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1101\/gad.255603","volume":"17","author":"T Sakai","year":"2003","unstructured":"Sakai, T. et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev. 17, 926\u2013940 (2003).","journal-title":"Genes Dev."},{"key":"55720_CR53","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/carcin\/bgm112","volume":"28","author":"K Honda","year":"2007","unstructured":"Honda, K. et al. Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk. Carcinogenesis 28, 2074\u20132081 (2007).","journal-title":"Carcinogenesis"},{"key":"55720_CR54","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/bjc.1993.194","volume":"67","author":"T Sakai","year":"1993","unstructured":"Sakai, T. et al. Specific expression of tenascin in human colonic neoplasms. Br. J. Cancer 67, 1058\u20131064 (1993).","journal-title":"Br. J. Cancer"},{"key":"55720_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100819","volume":"297","author":"K Ide","year":"2021","unstructured":"Ide, K. et al. The dipeptide prolyl-hydroxyproline promotes cellular homeostasis and lamellipodia-driven motility via active \u03b21-integrin in adult tendon cells. J. Biol. Chem. 297, 100819. https:\/\/doi.org\/10.1016\/j.jbc.2021.100819 (2021).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55720-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:05:34Z","timestamp":1786367134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55720-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55720"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55720-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Munir Pirmohamed currently receives partnership funding, paid to the University of Liverpool, for the MRC Medicines Development Fellowship Scheme (co-funded by MRC and GSK, AZ and Hammersmith Medicines Research). He has developed an HLA genotyping panel with MC Diagnostics but does not benefit financially from this. He is part of the IMI Consortium ARDAT (\n                      \n                      ); none of these funding sources have been used for the current research. No conflicts of interest, financial or otherwise, are declared by the other authors.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24689"}}